ANIK Q2 2022 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$40M+4.0% YoY

Gross Profit

$25M62.7% margin

Operating Income

-$3M-8.5% margin

Net Income

-$3M-7.2% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+8.1%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$1M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$354M

Total Liabilities

$68M

Stockholders' Equity

$286M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$38M	+4.0%
Gross Profit	$25M	$21M	+19.5%
Operating Income	-$3M	$9M	-136.8%
Net Income	-$3M	$7M	-143.5%

Revenue Segments

OA Pain Management

$26M65%

Joint Preservation and Restoration

$12M30%

Non-Orthopedic

$2M5%

Geographic Segments

UNITED STATES

$30M85%

Europe

$5M15%